Pulmonary Htn Flashcards

1
Q

Definition phtn

Normal value

A

Increase in mean pap> 25mmhg at rest as assessed by rh catheterization
14+_3 upper limit-20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is PAH

A

subgroup of ph with

Pawp<15 with pvr>3wood units in absence of other precapillary htn su h as lung diseases ,pte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Group 1 pah

A
Idiopathic
Familial - bmpr 2, alk-1
Ass with ctd/hiv/chd/portal htn/ parasites/ drugs
Pulm veno occlusive diaease
Persistent htn of new born
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Group 2

A

Phtn due to left heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Group 3

A

Due to limg disease/ hypoxemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Group 4

A
Cteph 
Other pulmonary artery obstruction- angio sarcoma 
Intravascular tumor
Areteritis
Cong.pa stenosis
Parasitic(hydatidosis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Group 5

A
Unclear or multifactorial mechansims
Hematological
Systemic disorder- sarcoid , lch, lam , nf
Metabolic- storage disorders.
Other- segmental htn
Crf
Fibrosing mediastinitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Who functional classification

A

1- no limitation of physical activity
2- slight limitation
3- marked
4@ inability to carryout any physical activity without symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathogenesis of group 1

A

Genetic +risk factors- endothelial cell injury and imbalance b/w vd and vc , apoptotic and mitogenic factors, thrombotic and antithromobtic
Causes vc, remodelling , thrombosis
Inc pa resistance ane pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathogenesis of group 2

A

Valvular disease - inc la pressures - interstitial edema + pa vc- vascular changes- pah

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathogenesis of group 3

A

Hypoxia- inc circuoatory bdnf (brain derived neurotrophic factor)
Dec no- dec vd
Smooth muscle proliferation
Inc vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pathogenesis group 4

A

Pe- incomplete resolution/organisation of thrombus- occlusion/ shear stress in non obstructed vessel - inc pa pressure and resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
Diagnosis
Ecg
Cxr
Echo
V/q
A

Rvh , cor pulmonale
Enlargement of central pulmonary arteries ,rvh
Pasp>40
For embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
Angio
Pft
Oximetry
Usg
6mwt
A
For embolism
Undrlying lung disease 
Osa
Portal htn
For severity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Right heart catheterization

A
To confirm diagnosis
At rest 25
Exercise 30
Wedge pressure <15
Pvr >240 dines cm sec
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
Vasoreactive test 
Why 
Recommended in whom
Agents
Interpretation 
Use
A

To detect residual properties of vadodilation of small pulmonary arteries and arterioles
In group 1
Inhaled no , enoprostenol iv. Adenosine
Pos- dec in 10 and value less than 40 with an increased or unchanged co and minimally reduced or unchanged bp
Use- in positive pts ,ccb high dose candidates

17
Q

Group 1 drug therapy

A

Ccb- nifedipine- 90-180mg /day
Diltiazem 240-720
Amlodepine 20
S/e- Hypotension, edema , syncope , rv failure

18
Q

Endothelial receptor antagonist

A

Ambrisentan 5-10
Bosentan 125be
Macitentan 3-10 /day

S/e: leg swelling , fluid retention, hepato Toxicity, teratogenic

19
Q

Pde5

A

Sildenafil 20 tds
Tadalafil
S/e - headache , chanegs in vision, not usedl with nitrates ,hypotensikn

20
Q

Guanylate cyclase inhibitor

A

Riociguat- 2.5 tds
Syncope , headache, edema , diarrhoea
C/I in pregnancy. Pde5 inh

21
Q

Ip receptor

A

Selexipag-

22
Q

Prostacyclin analouges

A

Epoprostenol-iv
Iloprost- inqhled iv
Treprostinil
Beraprsot- oral

Jawpain, diarrhoeaz achesvz

23
Q

Combination therapy

A

Macitentan plus sildenafil
Riociguat plus bosentan
Selecipag +era/pde5 inhibitors

24
Q

Algorithm

A

Vr test pos- ccb
Negative- who 2, 3- single or combination
4- initiak combination
Inadequate response- double/ triple-rx

25
Q

Sx

A

Balloon arterial septostomy
Benefit in fc-4 with rhf refractory to medical therapy
No mortality benefit

26
Q

Ix of lung tx

A

Nyh 3, 4 desoite 3 minths combination theraoy including prostanoids
Cardiac index less than 2 lit /m2
Mrap >15
6mwt- <35

27
Q

Group 2

A

Diuretics

Prostanoids. Era, pde5- some benefit

28
Q

3

A

Ltot

Ccb x

29
Q

Group 4

A

Life long anti coagulation
Diuretics o2
Riociguat
Ivf filter